Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types is a research paper published in Pharmaceuticals (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH-NHLBI
Grant: 2R15HL143545-02
FWCI
6.10
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords